Proline

Proline

SCHEMBL6986151

O=C(O)C(F)(F)F.O=C(O)C1CCCN1

nearest known ligand 0.53

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

SLC5A2

The experimentally established mechanism targets of Proline. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.42
BLM P54132 1/20 0.42
KMT2A Q03164 1/20 0.42
DPP4 P27487 4/20 0.41
DPP8 Q6V1X1 2/20 0.41
DPP9 Q86TI2 2/20 0.41
NOS2 P35228 2/20 0.41
NOS3 P29474 1/20 0.41
NOS1 P29475 1/20 0.41
HTR2C P28335 1/20 0.38
FAP Q12884 1/20 0.37
DPP7 Q9UHL4 1/20 0.37
PRCP P42785 1/20 0.36
SLC6A1 P30531 1/20 0.35
SLC6A11 P48066 1/20 0.35
TSHR P16473 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Proline SCHEMBL10781489 1.00 MEN1 (0.42) MEN1BLMKMT2ADPP4DPP8
Pipecolic Acid SCHEMBL30302226 0.94 MEN1 (0.37) MEN1BLMKMT2ADPP4DPP8
Trifluoroacetic Acid SCHEMBL20400915 0.90 MEN1 (0.42) MEN1BLMKMT2ATSHR
Trifluoroacetic Acid SCHEMBL20400912 0.90 MEN1 (0.42) MEN1BLMKMT2ATSHR
Proline SCHEMBL2939 0.87
Proline SCHEMBL10141185 0.87
Proline SCHEMBL13248912 0.87
D-Proline SCHEMBL21462052 0.87 BLM (0.52) MEN1BLMKMT2ADPP4DPP8
Proline SCHEMBL462226 0.87 BLM (0.52) MEN1BLMKMT2ADPP4DPP8
Proline SCHEMBL10141181 0.87

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109678859-B Dihydropyrimidine compound and application thereof in medicine 广东东阳光药业有限公司 2020-12-29 CN disclosed
EP-3697792-A1 DIHYDROPYRIMIDINE COMPOUNDS AND USES THEREOF IN MEDICINE Sunshine Lake Pharma Co., Ltd. (CN) 2020-08-26 EP disclosed
CN-110713484-A Xanthene fluorescent compound easy to combine and preparation and application thereof 罗宇峰 2020-01-21 CN disclosed
WO-2019076310-A1 DIHYDROPYRIMIDINE COMPOUNDS AND USES THEREOF IN MEDICINE SUNSHINE LAKE PHARMA CO., LTD. (CN) 2019-04-25 WO disclosed
CN-106715418-A Therapeutic compounds and methods of use thereof 基因泰克公司 2017-05-24 CN disclosed
CN-102159207-A Substituted pyrrolidine-2-carboxamides HOFFMANN LA ROCHE 2011-08-17 CN disclosed
EP-1358154-A2 PYRROLIDINE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS INHIBITORS OF NEURAMINIDASES Abbott Laboratories (US) 2003-11-05 EP disclosed
EP-1315698-A1 PYRROLIDINES AS INHIBITORS OF NEURAMINIDASES ABBOTT LABORATORIES (US) 2003-06-04 EP disclosed
WO-2001028996-A2 PYRROLIDINE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS INHIBITORS OF NEURAMINIDASES ABBOTT LABORATORIES (US) 2001-04-26 WO disclosed
WO-1999054299-A1 PYRROLIDINES AS INHIBITORS OF NEURAMINIDASES ABBOTT LABORATORIES (US) 1999-10-28 WO disclosed
CN-1217327-A D-proline derivative HOFFMANN LA ROCHE (CH) 1999-05-26 CN disclosed
EP-0084941-B1 AMIDE DERIVATIVES IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1987-03-11 EP disclosed